Hillhurst Biopharmaceuticals
Montrose, US · Delaware corporation
Founders & leadership
JF
Jeff FriedmanNamed on SEC filing
AG
Andrew GompertsNamed on SEC filing
EG
Edward GompertsNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 1 round · 2023
▶$1.8MraisedSep 2023 · 10 investors · BiotechnologyRule 506(b)
▶$1.8MraisedSep 2023 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeff FriedmanDirector
- Andrew GompertsExecutive Officer, Director
- Edward GompertsExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Hillhurst Biopharmaceuticals raised?
- Hillhurst Biopharmaceuticals has disclosed $1.8M raised across 1 round.
- Where is Hillhurst Biopharmaceuticals headquartered?
- Hillhurst Biopharmaceuticals is headquartered in Montrose, US.